VCRE NASDAQ
Vicore Pharma Holding AB
1W: -3.3%
YTD: -30.6%
$11.28
+0.22 (+1.99%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.2B
52W Range11-17.8
Volume1,760
Avg Volume59,486
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAhmed Mousa
Employees40
SectorHealthcare
IndustryBiotechnology
IPO Date2026-07-02
Websitevicorepharma.com
Kornhamnstorg 53
Stockholm, AB 171 65
SE
Stockholm, AB 171 65
SE
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
Latest News
No recent news
Recent Insider Trades
No insider trades found